Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

1 Killed in Crash on 91 Freeway Near Alameda Street


Lanes Closed for 4 Hours in Fatal Compton Accident

Fatal Accident 3

Compton, CA (September 30, 2019) – One person was killed in a crash in Compton. The fatal accident occurred on the evening of September 30 on the 91 Freeway.

The crash happened on the eastbound 91 Freeway, near Alameda Street. One person died at the accident scene. All lanes of the 91 Freeway were shut down for four hours.

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Compton

#90221


October 24, 2019

Bicyclist Killed in Crash at South Cherry Avenue

Korina Machuca Arrested for Intoxication in Fatal Fresno Accident Fresno, CA (O...


March 24, 2020

Crash on 15 Freeway Near Ontario Avenue Causes Major Injuries

2 Vehicles Involved in Corona Accident...


October 28, 2019

Man Killed in Pedestrian Crash at Main and East 9th Streets

Victim Hit by Car in Fatal Chico Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.